Table 2. Relationship Between Serum Zinc and Patients’ Characteristics (Continuous Variables).
| │r│ | P value | |
|---|---|---|
| Age (y/o) | 0.253 | 0.0014 |
| BMI (kg/m2) | 0.158 | 0.067 |
| Platelets count (× 103/mm3) | 0.189 | 0.0177 |
| AST (IU/L) | 0.245 | 0.002 |
| ALT (IU/L) | 0.077 | 0.3384 |
| Albumin (g/dL) | 0.587 | < 0.0001 |
| Total bilirubin (mg/dL) | 0.222 | 0.0053 |
| Prothrombin time (international normalized ratio) | 0.255 | 0.0029 |
| Creatinine (mg/dL) | 0.149 | 0.0688 |
| BUN (mg/dL) | 0.128 | 0.1231 |
| BCAA-to-tyrosine ratio (BTR) | 0.357 | < 0.0001 |
| Child-Pugh score | 0.469 | < 0.0001 |
| Ammonia (µg/dL) | 0.246 | 0.0028 |
| Total cholesterol (mg/dL) | 0.314 | < 0.0001 |
| Triglycerides (mg/dL) | 0.079 | 0.3493 |
| Fasting blood glucose (mg/dL) | 0.076 | 0.3527 |
| HbA1c (%) | 0.115 | 0.1623 |
| HOMA-IR | 0.072 | 0.4165 |
| Ferritin (ng/mL) | 0.069 | 0.4146 |
| AFP (ng/mL) | 0.17 | 0.0344 |
y/o: years old; BMI: body mass index; AST: aspartate aminotransferase; ALT: alanine aminotransferase; BUN: blood urea nitrogen; BCAA: branched-chain amino acid; HOMA-IR: homeostasis model assessment-insulin resistance; AFP: alpha-fetoprotein; DM: diabetes mellitus.